Avalyn Pharma Director Robert J. Meyer files initial beneficial ownership statement
AVLN•Form 3 filing by director
- Avalyn Pharma director Robert J. Meyer filed an initial Form 3 beneficial ownership statement dated Sept. 15, 2026.*
AVLN•AVLN•AVLN•
